Literature DB >> 32628153

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy.

Thomas Reiberger1, Philipp Schwabl2, Michael Trauner2, Markus Peck-Radosavljevic3, Mattias Mandorfer2.   

Abstract

Here we provide a detailed protocol describing the clinical procedure of hepatic venous pressure gradient (HVPG) measurement in patients with advanced chronic liver disease followed by an instruction for transjugular biopsy. Under local anesthesia and ultrasound guidance, a catheter introducer sheath is placed in the right internal jugular vein. Using fluoroscopic guidance, a balloon catheter is advanced into the inferior vena cava (IVC) and inserted into a large hepatic vein. Correct and sufficient wedge position of the catheter is ensured by injecting contrast media while the balloon is blocking the outflow of the cannulated hepatic vein. After calibrating the external pressure transducer, continuous pressure recordings are obtained with triplicate recordings of the wedged hepatic venous pressure (WHVP) and free hepatic venous pressure (FHVP). The difference between FHVP and WHVP is referred to as HVPG, with values ≥10 mm Hg indicating clinically significant portal hypertension (CSPH). Before removing the catheter, pressure readings obtained in the IVC at the same level, as well as the right atrial pressure are recorded. Finally, a transjugular liver biopsy can be obtained via the same vascular route. Different systems are available; however, core biopsy needles are preferred over aspiration needles, especially for cirrhotic livers. Again, under fluoroscopic guidance a biopsy needle introducer sheath is advanced into an hepatic vein. Next, the transjugular biopsy needle is gently advanced through the introducer sheath: (i) in case of aspiration biopsy, the needle is advanced into the liver parenchyma under aspiration and then removed quickly, or (ii) in case of a core biopsy, the cutting-mechanism is triggered inside the parenchyma. Several separate passages can be safely performed to obtain sufficient liver specimens via transjugular biopsy. In experienced hands, the combination of these procedures takes about 30-45 min.

Entities:  

Year:  2020        PMID: 32628153     DOI: 10.3791/58819

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies.

Authors:  Philipp Königshofer; Benedikt Silvester Hofer; Ksenia Brusilovskaya; Benedikt Simbrunner; Oleksandr Petrenko; Katharina Wöran; Merima Herac; Judith Stift; Katharina Lampichler; Gerald Timelthaler; David Bauer; Lukas Hartl; Bernhard Robl; Maria Sibila; Bruno K Podesser; Georg Oberhuber; Philipp Schwabl; Mattias Mandorfer; Michael Trauner; Thomas Reiberger
Journal:  Hepatology       Date:  2021-12-20       Impact factor: 17.298

2.  Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.

Authors:  Benedikt Simbrunner; Rodrig Marculescu; Bernhard Scheiner; Philipp Schwabl; Theresa Bucsics; Alexander Stadlmann; David J M Bauer; Rafael Paternostro; Ernst Eigenbauer; Matthias Pinter; Albert Friedrich Stättermayer; Michael Trauner; Mattias Mandorfer; Thomas Reiberger
Journal:  Liver Int       Date:  2020-05-18       Impact factor: 5.828

3.  Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis.

Authors:  Benedikt Simbrunner; Georg Semmler; Alexander Stadlmann; Bernhard Scheiner; Philipp Schwabl; Rafael Paternostro; Theresa Bucsics; David Bauer; Ernst Eigenbauer; Matthias Pinter; Albert-Friedrich Stättermayer; Peter Quehenberger; Rodrig Marculescu; Michael Trauner; Mattias Mandorfer; Thomas Reiberger
Journal:  Hepatol Int       Date:  2020-12-08       Impact factor: 6.047

Review 4.  Congestive Hepatopathy.

Authors:  José Ignacio Fortea; Ángela Puente; Antonio Cuadrado; Patricia Huelin; Raúl Pellón; Francisco José González Sánchez; Marta Mayorga; María Luisa Cagigal; Inés García Carrera; Marina Cobreros; Javier Crespo; Emilio Fábrega
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

5.  Effect of liver resection-induced increases in hepatic venous pressure gradient on development of postoperative acute kidney injury.

Authors:  Christian Reiterer; Alexander Taschner; Florian Luf; Manfred Hecking; Dietmar Tamandl; Oliver Zotti; Thomas Reiberger; Patrick Starlinger; Mattias Mandorfer; Edith Fleischmann
Journal:  BMC Nephrol       Date:  2022-01-08       Impact factor: 2.388

6.  The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.

Authors:  Patrick Starlinger; Joseph C Ahn; Aidan Mullan; Georg P Gyoeri; David Pereyra; Roberto Alva-Ruiz; Hubert Hackl; Thomas Reiberger; Michael Trauner; Jonas Santol; Benedikt Simbrunner; Mattias Mandorfer; Gabriela Berlakovich; Patrick S Kamath; Julie Heimbach
Journal:  Hepatology       Date:  2021-08-29       Impact factor: 17.425

7.  Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.

Authors:  Lukas Burghart; Emina Halilbasic; Philipp Schwabl; Benedikt Simbrunner; Albert Friedrich Stättermayer; Oleksandr Petrenko; Bernhard Scheiner; David Bauer; Matthias Pinter; Kaan Boztug; Mattias Mandorfer; Michael Trauner; Thomas Reiberger
Journal:  J Gastroenterol       Date:  2021-12-11       Impact factor: 7.527

8.  Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression.

Authors:  Mathias Jachs; Lukas Hartl; David Bauer; Benedikt Simbrunner; Albert Friedrich Stättermayer; Robert Strassl; Michael Trauner; Mattias Mandorfer; Thomas Reiberger
Journal:  J Pers Med       Date:  2022-02-08

9.  Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure.

Authors:  Lorenz Balcar; Georg Semmler; Katharina Pomej; Benedikt Simbrunner; David Bauer; Lukas Hartl; Mathias Jachs; Rafael Paternostro; Theresa Bucsics; Matthias Pinter; Michael Trauner; Mattias Mandorfer; Thomas Reiberger; Bernhard Scheiner
Journal:  United European Gastroenterol J       Date:  2021-05       Impact factor: 4.623

10.  Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19.

Authors:  Lukas Hartl; Mathias Jachs; Benedikt Simbrunner; David J M Bauer; Georg Semmler; Daniela Gompelmann; Thomas Szekeres; Peter Quehenberger; Michael Trauner; Mattias Mandorfer; Bernhard Scheiner; Thomas Reiberger
Journal:  J Pers Med       Date:  2021-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.